ng-nitroarginine methyl ester has been researched along with Anemia, Sickle Cell in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (20.00) | 18.2507 |
2000's | 4 (40.00) | 29.6817 |
2010's | 1 (10.00) | 24.3611 |
2020's | 3 (30.00) | 2.80 |
Authors | Studies |
---|---|
Archer, DR; Brown, LA; Hansen, L; Hurtado, J; Joseph, G; Jun, HW; Lewis, CV; Sellak, H; Taylor, WR | 1 |
Ivo, ML; Monteiro, GM; Parisotto, EB; Ramalho, RT; Rodrigues, CT; Santos Neto, ATD; Silva, IS | 1 |
Ajayi, IO; Azubuike-Osu, S; Ebeigbe, AB; Uche, OK | 1 |
Baliga, BS; Haynes, J; Mishra, N; Obiako, B | 1 |
Chang, HY; Fabry, ME; Kaul, DK; Liu, XD; Nagel, RL | 1 |
Dasgupta, T; Hebbel, RP; Kaul, DK | 1 |
Dasgupta, T; Fabry, ME; Kaul, DK; Zhang, X | 1 |
Arruda, VR; Condino-Neto, A; Costa, FF; De Nucci, G; Dias-Da-Motta, P; MuscarĂ¡, MN; Saad, ST | 1 |
French, JA; Hillery, CA; Hoffmann, RG; Hudetz, AG; Kenny, D; Scott, JP; Wood, JD | 1 |
Fabry, ME; Kaul, DK; Liu, XD; Nagel, RL | 1 |
10 other study(ies) available for ng-nitroarginine methyl ester and Anemia, Sickle Cell
Article | Year |
---|---|
Increasing nitric oxide bioavailability fails to improve collateral vessel formation in humanized sickle cell mice.
Topics: Anemia, Sickle Cell; Animals; Arginine; Biological Availability; Drinking Water; Hindlimb; Ischemia; Mice; Muscle, Skeletal; Necrosis; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Regional Blood Flow | 2022 |
Effects of oxidative stress on liver, brain and spinal cord of rats using L-NAME and treated with hydroxyurea. A model of sickle cell complication.
Topics: Anemia, Sickle Cell; Animals; Brain; Disease Models, Animal; Hydroxyurea; Liver; Male; NG-Nitroarginine Methyl Ester; Oxidative Stress; Rats; Rats, Wistar; Spinal Cord | 2020 |
Mechanisms of enhanced vascular smooth muscle contraction induced by sickle erythrocyte constituents.
Topics: Acetylcholine; Anemia, Sickle Cell; Animals; Carotid Arteries; Endothelium, Vascular; Erythrocytes; Muscle Contraction; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Phenylephrine; Rabbits; Vasodilator Agents | 2020 |
Combined effects of arginine and hydroxyurea on BFU-E derived colony growth and HbF synthesis in erythroid progenitors isolated from sickle cell blood.
Topics: Anemia, Sickle Cell; Arginine; Cell Proliferation; Erythroid Precursor Cells; Fetal Hemoglobin; Humans; Hydroxyurea; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase | 2010 |
Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice.
Topics: Acetylcholine; Anemia, Sickle Cell; Animals; Cell Adhesion; Cyclooxygenase 2; Endothelium, Vascular; Enzyme Inhibitors; Female; Fetal Hemoglobin; Hemodynamics; Hemoglobin, Sickle; Hemolysis; Humans; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microcirculation; Muscle, Skeletal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Oxidative Stress; Prostaglandin-Endoperoxide Synthases; Tyrosine; Vasodilation; Vasodilator Agents | 2004 |
Protective effect of arginine on oxidative stress in transgenic sickle mouse models.
Topics: Anemia, Sickle Cell; Animals; Antioxidants; Arginine; Catalase; Dietary Supplements; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Mice; Mice, Inbred C57BL; Mice, Transgenic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Superoxide Dismutase | 2006 |
Arginine therapy of transgenic-knockout sickle mice improves microvascular function by reducing non-nitric oxide vasodilators, hemolysis, and oxidative stress.
Topics: Acetylcholine; Anemia, Sickle Cell; Animals; Arginine; Citrulline; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Enzyme Inhibitors; Globins; Heme Oxygenase-1; Hemodynamics; Hemoglobins; Hemolysis; Humans; Membrane Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitroprusside; Oxidative Stress; Tyrosine; Vasodilator Agents | 2008 |
The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia.
Topics: Adolescent; Adult; Anemia, Sickle Cell; Arginine; Female; Humans; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Platelet Aggregation; Superoxide Dismutase; Superoxides | 1996 |
Mechanisms of stroke in sickle cell disease: sickle erythrocytes decrease cerebral blood flow in rats after nitric oxide synthase inhibition.
Topics: Anemia, Sickle Cell; Animals; Cell Adhesion; Cerebrovascular Circulation; Cerebrovascular Disorders; Endothelium, Vascular; Enzyme Inhibitors; Erythrocytes, Abnormal; Humans; Laser-Doppler Flowmetry; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1997 |
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse.
Topics: Anemia, Sickle Cell; Animals; Arginine; Blood Pressure; Colforsin; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Hemoglobin, Sickle; Humans; Indomethacin; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Vasodilation; Vasodilator Agents | 2000 |